artesunic acid has been researched along with Burkitt Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, ZX; Wang, N; Yin, JL; Zeng, GZ | 1 |
| Han, QK; Liu, Y; Lu, C; Wang, H; Wang, ZC | 1 |
2 other study(ies) available for artesunic acid and Burkitt Lymphoma
| Article | Year |
|---|---|
Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma.
Topics: Activating Transcription Factor 4; Antineoplastic Agents; Artesunate; Burkitt Lymphoma; Cell Death; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ferroptosis; gamma-Glutamylcyclotransferase; Humans; Transcription Factor CHOP; Tumor Cells, Cultured | 2019 |
Research on the relationship between artesunate and Raji cell autophagy and apoptosis of Burkitt's lymphoma and its mechanism.
Topics: Apoptosis; Artemisinins; Artesunate; Autophagy; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Humans | 2017 |